Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Orthopediatrics (KIDS) Debt to Equity (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Debt to Equity for 10 consecutive years, with $0.01 as the latest value for Q4 2025.

  • On a quarterly basis, Debt to Equity rose 508.39% to $0.01 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.01, a 508.39% increase, with the full-year FY2025 number at $0.01, up 508.39% from a year prior.
  • Debt to Equity was $0.01 for Q4 2025 at Orthopediatrics, up from $0.01 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.21 in Q1 2025 to a low of $0.0 in Q2 2025.
  • A 5-year average of $0.02 and a median of $0.0 in 2022 define the central range for Debt to Equity.
  • Peak YoY movement for Debt to Equity: surged 2707.09% in 2022, then plummeted 98.44% in 2023.
  • Orthopediatrics' Debt to Equity stood at $0.0 in 2021, then crashed by 48.29% to $0.0 in 2022, then soared by 1013.93% to $0.03 in 2023, then tumbled by 91.6% to $0.0 in 2024, then surged by 508.39% to $0.01 in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Debt to Equity are $0.01 (Q4 2025), $0.01 (Q3 2025), and $0.0 (Q2 2025).